JOHN JONAS

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023.

Advocating on behalf of ASC reimbursement and payment policy, including HR 972/S312 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S 1130 Health Care Prices Revealed and Information to Consumers Explained Transparency Act or the Health Care PRICE Transparency Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; cardiac care; and health infrastructure funding and initiatives. Hospital at Home. S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 1319, the American Rescue Plan Act (P.L. 117-2); H.R. 1330, the Patient Access to Higher Quality Care Act; H.R. 5376 the Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. Executive Order 14042, Requirements for COVID-19 Vaccination of Federal Contractors and DOL OSHA COVID-19 Vaccination Rule. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 4502 - FY2022 Consolidated Appropriations, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, cardiac care, and health infrastructure funding and initiatives, Hospital at Home. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 5376 the Build Back Better Act, H.R.8295 Labor-HHS FY23 Appropriations, H.Res.1177 Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, cardiac care, and health infrastructure funding and initiatives, Hospital at Home. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; cardiac care; and health infrastructure funding and initiatives. Hospital at Home. S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 1319, the American Rescue Plan Act (P.L. 117-2); H.R. 1330, the Patient Access to Higher Quality Care Act; H.R. 5376 the Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. Executive Order 14042, Requirements for COVID-19 Vaccination of Federal Contractors and DOL OSHA COVID-19 Vaccination Rule. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 4502 - FY2022 Consolidated Appropriations, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, cardiac care, and health infrastructure funding and initiatives, Hospital at Home. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 5376 the Build Back Better Act, H.R.8295 Labor-HHS FY23 Appropriations, H.Res.1177 Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, cardiac care, and health infrastructure funding and initiatives, Hospital at Home. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, safe mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/ S.3062 Labor-HHS FY 22 Appropriations, H.R. 2471 FY 2022 Omnibus Appropriation, S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 5376 the Build Back Better Act, H.R.8295 Labor-HHS FY23 Appropriations, H.Res.1177 Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

H.R. 2471 FY 2022 Omnibus Appropriations, H.R. 4502/ S.3062 Labor-HHS FY 22 Appropriations, H.R.8295 Labor-HHS FY23 Appropriations. Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid and safe mobility issues. Monitor drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues, H.Res.1177 Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

H.R. 2471 FY 2022 Omnibus Appropriations, H.R. 4502/ S.3062 Labor-HHS FY 22 Appropriations. Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid and safe mobility issues. Monitor drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues.

H.R. 2471 FY2022 Omnibus Appropriations; H.R. 4502/S.3062 Labor-HHS FY2022 Appropriations; H.R.8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, and Medicare and Medicaid. Monitor drug pricing, medical device, innovation, telemedicine/telehealth, supply chain, and provider issues. Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; diabetes (including diabetic retinopathy); cardiac care; safe mobility standards; safe patient handling; and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/S.3062 Labor-HHS FY2022 Appropriations; H.R. 2471 FY2022 Omnibus Appropriation; S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 5376 The Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, safe mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/ S.3062 Labor-HHS FY 22 Appropriations, H.R. 2471 FY 2022 Omnibus Appropriation, S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, safe mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/ S.3062 Labor-HHS FY 22 Appropriations, H.R. 2471 FY 2022 Omnibus Appropriation, S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; diabetes (including diabetic retinopathy); cardiac care; safe mobility standards; safe patient handling; and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/S.3062 Labor-HHS FY2022 Appropriations; H.R. 2471 FY2022 Omnibus Appropriation; S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 5376 The Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, cardiac care, and health infrastructure funding and initiatives, Hospital at Home. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; cardiac care; and health infrastructure funding and initiatives. Hospital at Home. S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 1319, the American Rescue Plan Act (P.L. 117-2); H.R. 1330, the Patient Access to Higher Quality Care Act; H.R. 5376 the Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, safe mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/ S.3062 Labor-HHS FY 22 Appropriations, H.R. 2471 FY 2022 Omnibus Appropriation, S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 5376 the Build Back Better Act, H.R.8295 Labor-HHS FY23 Appropriations, H.Res.1177 Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. Executive Order 14042, Requirements for COVID-19 Vaccination of Federal Contractors and DOL OSHA COVID-19 Vaccination Rule. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 4502 - FY2022 Consolidated Appropriations, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, cardiac care, and health infrastructure funding and initiatives, Hospital at Home. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 5376 the Build Back Better Act, H.R.8295 Labor-HHS FY23 Appropriations, H.Res.1177 Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding, medical technology and device innovation, supply chain issues, Medicare and Medicaid coverage and reimbursement, artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, cardiac care, and health infrastructure funding and initiatives. Hospital at Home. Health provisions of the Consolidated Appropriations Act, 2023 (Omnibus) (P.L. No: 117-328) including the Food and Drug Omnibus Reform Act (FDORA) and PREVENT Pandemics Act, and Labor-HHS Appropriations for FY23. H.R. 4346, the CHIPS and Science Act of 2022 (P.L. No: 117-167). Safe mobility issues, including H.Res.1177, Expressing the Sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Health provisions of the Consolidated Appropriations Act, 2023 (Omnibus) (P.L. No: 117-328) including the Food and Drug Omnibus Reform Act (FDORA) and PREVENT Pandemics Act, and Labor-HHS Appropriations for FY23. H.R. 4346, the CHIPS and Science Act of 2022 (P.L. No: 117-167). Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, and Medicare and Medicaid. Monitor drug pricing, medical device, innovation, telemedicine/telehealth, supply chain, and provider issues. Safe mobility issues, including H.Res.1177, Expressing the Sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding, medical technology and device innovation, supply chain issues, Medicare and Medicaid coverage and reimbursement, artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, safe mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. Health provisions of the Consolidated Appropriations Act, 2023 (Omnibus) (P.L. No: 117-328) including the Food and Drug Omnibus Reform Act (FDORA) and PREVENT Pandemics Act, and Labor-HHS Appropriations for FY23. H.R. 6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180). H.R. 4346, the CHIPS and Science Act of 2022 (P.L. No: 117-167). Safe mobility issues, including H.Res.1177, Expressing the Sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; diabetes (including diabetic retinopathy); cardiac care; safe mobility standards; safe patient handling; and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/S.3062 Labor-HHS FY2022 Appropriations; H.R. 2471 FY2022 Omnibus Appropriation; S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 5376 The Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; cardiac care; and health infrastructure funding and initiatives. Hospital at Home. S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 1319, the American Rescue Plan Act (P.L. 117-2); H.R. 1330, the Patient Access to Higher Quality Care Act; H.R. 5376 the Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

H.R. 2471 FY2022 Omnibus Appropriations; H.R. 4502/S.3062 Labor-HHS FY2022 Appropriations; H.R.8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, and Medicare and Medicaid. Monitor drug pricing, medical device, innovation, telemedicine/telehealth, supply chain, and provider issues. Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

H.R. 2471 FY2022 Omnibus Appropriations; H.R. 4502/S.3062 Labor-HHS FY2022 Appropriations; H.R.8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, and Medicare and Medicaid. Monitor drug pricing, medical device, innovation, telemedicine/telehealth, supply chain, and provider issues. Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; diabetes (including diabetic retinopathy); cardiac care; safe mobility standards; safe patient handling; and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/S.3062 Labor-HHS FY2022 Appropriations; H.R. 2471 FY2022 Omnibus Appropriation; S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 5376 The Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. Executive Order 14042, Requirements for COVID-19 Vaccination of Federal Contractors and DOL OSHA COVID-19 Vaccination Rule. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 4502 - FY2022 Consolidated Appropriations, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, safe mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/ S.3062 Labor-HHS FY 22 Appropriations, H.R. 2471 FY 2022 Omnibus Appropriation, S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 5376 the Build Back Better Act, H.R.8295 Labor-HHS FY23 Appropriations, H.Res.1177 Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, safe mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/ S.3062 Labor-HHS FY 22 Appropriations, H.R. 2471 FY 2022 Omnibus Appropriation, S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 5376 the Build Back Better Act.

H.R. 2471 FY 2022 Omnibus Appropriations, H.R. 4502/ S.3062 Labor-HHS FY 22 Appropriations, H.R.8295 Labor-HHS FY23 Appropriations. Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid and safe mobility issues. Monitor drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues, H.Res.1177 Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

H.R. 2471 FY 2022 Omnibus Appropriations, H.R. 4502/ S.3062 Labor-HHS FY 22 Appropriations. Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid and safe mobility issues. Monitor drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues.

Advocating on behalf of ASC reimbursement and payment policy including HR 5815/S3132 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2021.

Advocating on behalf of ASC reimbursement and payment policy including HR 5815/S3132 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2021.

Advocating on behalf of ASC reimbursement and payment policy including HR 5815/S3132 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2021.

Issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. Executive Order 14042, Requirements for COVID-19 Vaccination of Federal Contractors and DOL OSHA COVID-19 Vaccination Rule. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 4502 - FY2022 Consolidated Appropriations, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, cardiac care, and health infrastructure funding and initiatives, Hospital at Home. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 5376 the Build Back Better Act, H.R.8295 Labor-HHS FY23 Appropriations, H.Res.1177 Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; cardiac care; and health infrastructure funding and initiatives. Hospital at Home. S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 1319, the American Rescue Plan Act (P.L. 117-2); H.R. 1330, the Patient Access to Higher Quality Care Act; H.R. 5376 the Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, cardiac care, and health infrastructure funding and initiatives, Hospital at Home. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; diabetes (including diabetic retinopathy); cardiac care; safe mobility standards; safe patient handling; and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/S.3062 Labor-HHS FY2022 Appropriations; H.R. 2471 FY2022 Omnibus Appropriation; S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 5376 The Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, safe mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/ S.3062 Labor-HHS FY 22 Appropriations, H.R. 2471 FY 2022 Omnibus Appropriation, S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 5376 the Build Back Better Act.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, safe mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/ S.3062 Labor-HHS FY 22 Appropriations, H.R. 2471 FY 2022 Omnibus Appropriation, S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 5376 the Build Back Better Act, H.R.8295 Labor-HHS FY23 Appropriations, H.Res.1177 Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Advocating on behalf of ASC reimbursement and payment policy including HR 5815/S3132 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2021.

Advocating on behalf of ASC reimbursement and payment policy including HR 5815/S3132 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2021.

Advocating on behalf of ASC reimbursement and payment policy including HR 5815/S3132 - the Outpatient Surgery and Quality Access Act. H.R. 5181 - Outpatient Surgery Quality and Access Act of 2021.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding, medical technology and device innovation, supply chain issues, Medicare and Medicaid coverage and reimbursement, artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, safe mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. Health provisions of the Consolidated Appropriations Act, 2023 (Omnibus) (P.L. No: 117-328) including the Food and Drug Omnibus Reform Act (FDORA) and PREVENT Pandemics Act, and Labor-HHS Appropriations for FY23. H.R. 6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180). H.R. 4346, the CHIPS and Science Act of 2022 (P.L. No: 117-167). Safe mobility issues, including H.Res.1177, Expressing the Sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

H.R. 2471 FY2022 Omnibus Appropriations; H.R. 4502/S.3062 Labor-HHS FY2022 Appropriations; H.R.8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, and Medicare and Medicaid. Monitor drug pricing, medical device, innovation, telemedicine/telehealth, supply chain, and provider issues. Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; diabetes (including diabetic retinopathy); cardiac care; safe mobility standards; safe patient handling; and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/S.3062 Labor-HHS FY2022 Appropriations; H.R. 2471 FY2022 Omnibus Appropriation; S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 5376 The Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; cardiac care; and health infrastructure funding and initiatives. Hospital at Home. S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 1319, the American Rescue Plan Act (P.L. 117-2); H.R. 1330, the Patient Access to Higher Quality Care Act; H.R. 5376 the Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Promote SIDM's policy agenda to increase Federal funding into research to improve diagnosis and patient safety. Support for S. 4468 - Improving Diagnosis in Medicine Act of 2022; H.R. 8172 - Improving Diagnosis in Medicine Act of 2022.

Promote SIDM's policy agenda to increase Federal funding into research to improve diagnosis and patient safety. Support for S. 4468 - Improving Diagnosis in Medicine Act of 2022; H.R. 8172 - Improving Diagnosis in Medicine Act of 2022.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; cardiac care; and health infrastructure funding and initiatives. Hospital at Home. S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 1319, the American Rescue Plan Act (P.L. 117-2); H.R. 1330, the Patient Access to Higher Quality Care Act; H.R. 5376 the Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

H.R. 2471 FY2022 Omnibus Appropriations; H.R. 4502/S.3062 Labor-HHS FY2022 Appropriations; H.R.8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, and Medicare and Medicaid. Monitor drug pricing, medical device, innovation, telemedicine/telehealth, supply chain, and provider issues. Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; diabetes (including diabetic retinopathy); cardiac care; safe mobility standards; safe patient handling; and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/S.3062 Labor-HHS FY2022 Appropriations; H.R. 2471 FY2022 Omnibus Appropriation; S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 5376 The Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

H.R. 2471 FY 2022 Omnibus Appropriations, H.R. 4502/ S.3062 Labor-HHS FY 22 Appropriations, H.R.8295 Labor-HHS FY23 Appropriations. Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid and safe mobility issues. Monitor drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues, H.Res.1177 Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including diabetes and diabetic retinopathy, Medicare and Medicaid, safe mobility issues, drug pricing, medical device, innovation, telemedicine/ telehealth, supply chain, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, diabetes (including diabetic retinopathy), cardiac care, safe mobility standards, safe patient handling, and health infrastructure funding and initiatives. Hospital at Home. H.R. 4502/ S.3062 Labor-HHS FY 22 Appropriations, H.R. 2471 FY 2022 Omnibus Appropriation, S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 5376 the Build Back Better Act, H.R.8295 Labor-HHS FY23 Appropriations, H.Res.1177 Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges, the Public Health Emergency (PHE), pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence, health care reform, rural health, telehealth, telemedicine, remote patient monitoring, quality measurement and outcomes, cardiac care, and health infrastructure funding and initiatives, Hospital at Home. S. 748, the Medicare Sequester Relief Act, H.R. 315, the Medicare Sequester COVID Moratorium Act, H.R. 1319, the American Rescue Plan Act, P.L. 117-2, H.R. 1330, the Patient Access to Higher Quality Care Act, H.R. 5376 the Build Back Better Act, H.R.8295 Labor-HHS FY23 Appropriations, H.Res.1177 Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.

Regulatory and reimbursement policy issues relating to healthcare programs, including Medicare and Medicaid coverage and reimbursement, safe mobility issues, diabetes and diabetic retinopathy, monitor medical device, drug pricing, supply chain, innovation, and provider issues. Monitor issues regarding COVID short and long term challenges; the Public Health Emergency (PHE); pandemic issues and provider relief funding; medical technology and device innovation; supply chain issues; Medicare and Medicaid coverage and reimbursement; artificial intelligence; health care reform; rural health; telehealth; telemedicine; remote patient monitoring; quality measurement and outcomes; cardiac care; and health infrastructure funding and initiatives. Hospital at Home. S. 748, the Medicare Sequester Relief Act; H.R. 315, the Medicare Sequester COVID Moratorium Act; H.R. 1319, the American Rescue Plan Act (P.L. 117-2); H.R. 1330, the Patient Access to Higher Quality Care Act; H.R. 5376 the Inflation Reduction Act of 2022 (P.L. No: 117-169); H.R. 8295 Labor-HHS FY2023 Appropriations; H.R. 6833 Making continuing appropriations for fiscal year 2023, and for other purposes (P.L. No: 117-180); H.R. 4346 The CHIPS and Science Act of 2022 (P.L. No: 117-167). Medical Device User Fee Amendments Reauthorization, included in P.L. No: 117-180. Safe mobility issues, including H.Res.1177, Expressing the sense of the House of Representatives regarding the Centers for Medicare & Medicaid Services developing a mobility metric to guide providers in preventing mobility loss among hospitalized older adults.